{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:56:05Z","timestamp":1787583365474,"version":"build-2736575974"},"reference-count":118,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.neurol.2023.02.064","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T08:05:11Z","timestamp":1678435511000},"page":"831-843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies"],"prefix":"10.1016","volume":"179","author":[{"given":"R.","family":"Collet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Caballero-\u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Querol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neurol.2023.02.064_bib0595","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41572-018-0027-2","article-title":"Immune-mediated neuropathies","volume":"4","author":"Kieseier","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"10.1016\/j.neurol.2023.02.064_bib0600","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrneurol.2017.84","article-title":"Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications","volume":"13","author":"Querol","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"10.1016\/j.neurol.2023.02.064_bib0605","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"Van den Berg","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"24","key":"10.1016\/j.neurol.2023.02.064_bib0610","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N Engl J Med"},{"issue":"10045","key":"10.1016\/j.neurol.2023.02.064_bib0615","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.neurol.2023.02.064_bib0620","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrneurol.2014.117","article-title":"Diagnosis and treatment of chronic acquired demyelinating polyneuropathies","volume":"10","author":"Latov","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2023.02.064_bib0625","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/WCO.0000000000000725","article-title":"Autoantibodies in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"32","author":"Pascual-Go\u00f1i","year":"2019","journal-title":"Curr Opin Neurol"},{"issue":"9","key":"10.1016\/j.neurol.2023.02.064_bib0630","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.medcli.2019.06.007","article-title":"Autoantibodies in immune-mediated inflammatory neuropathies","volume":"153","author":"Mart\u00edn-Aguilar","year":"2019","journal-title":"Med Clin (Barc)"},{"issue":"6","key":"10.1016\/j.neurol.2023.02.064_bib0635","doi-asserted-by":"crossref","first-page":"4986504","DOI":"10.1212\/WNL.0000000000001833","article-title":"CIDP diagnostic pitfalls and perception of treatment benefit","volume":"85","author":"Allen","year":"2015","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neurol.2023.02.064_bib0640","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410310619","article-title":"Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome","volume":"31","author":"Chiba","year":"1992","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.neurol.2023.02.064_bib0645","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1093\/brain\/aww189","article-title":"Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy","volume":"139","author":"Doppler","year":"2016","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.neurol.2023.02.064_bib0650","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/brain\/awx124","article-title":"Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy","volume":"140","author":"Delmont","year":"2017","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.neurol.2023.02.064_bib0655","doi-asserted-by":"crossref","first-page":"370680","DOI":"10.1002\/ana.23794","article-title":"Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Querol","year":"2013","journal-title":"Ann Neurol"},{"issue":"23","key":"10.1016\/j.neurol.2023.02.064_bib0660","first-page":"224168","article-title":"Neurofascin as a target for autoantibodies in peripheral neuropathies","volume":"79","author":"Man","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurol.2023.02.064_bib0665","doi-asserted-by":"crossref","first-page":"123633","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: A systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"issue":"11","key":"10.1016\/j.neurol.2023.02.064_bib0670","doi-asserted-by":"crossref","first-page":"671683","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain6Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"10.1016\/j.neurol.2023.02.064_bib0675","doi-asserted-by":"crossref","first-page":"1186695","DOI":"10.1136\/jnnp-2014-310097","article-title":"Nodopathies of the peripheral nerve: An emerging concept","volume":"86","author":"Uncini","year":"2015","journal-title":"Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.neurol.2023.02.064_bib0680","doi-asserted-by":"crossref","first-page":"2866677","DOI":"10.1093\/brain\/awy232","article-title":"Regional variation of Guillain-Barr\u00e9 syndrome","volume":"141","author":"Doets","year":"2018","journal-title":"Brain"},{"issue":"1S","key":"10.1016\/j.neurol.2023.02.064_bib0685","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2023.02.064_bib0690","first-page":"596141","article-title":"The Landry-Guillain-Barr\u00e9 syndrome; a clinicopathologic report of 50 fatal cases and a critique of the literature","volume":"28","author":"Haymaker","year":"1949","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.neurol.2023.02.064_bib0695","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.nrl.2018.06.002","article-title":"Axonal pathology in early stages of Guillain-Barr\u00e9 syndrome","volume":"37","author":"Berciano","year":"2022","journal-title":"Neurologia (Engl Ed)"},{"issue":"1","key":"10.1016\/j.neurol.2023.02.064_bib0700","doi-asserted-by":"crossref","first-page":"33651","DOI":"10.1007\/BF02284784","article-title":"Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barr\u00e9 syndrome","volume":"25","author":"Griffin","year":"1996","journal-title":"J Neurocytol"},{"issue":"5","key":"10.1016\/j.neurol.2023.02.064_bib0705","doi-asserted-by":"crossref","first-page":"625635","DOI":"10.1002\/ana.410390512","article-title":"Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy","volume":"39","author":"Hafer-Macko","year":"1996","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.neurol.2023.02.064_bib0710","doi-asserted-by":"crossref","first-page":"723631","DOI":"10.1038\/nrneurol.2016.172","article-title":"Guillain-Barr\u00e9 syndrome: A century of progress","volume":"12","author":"Goodfellow","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2023.02.064_bib0715","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/brain\/awg030","article-title":"Autoimmunoreactivity to Schwann cells in patients with inflammatory neuropathies","volume":"126","author":"Kwa","year":"2003","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neurol.2023.02.064_bib0720","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1186\/s12974-021-02301-0","article-title":"Autoantibody screening in Guillain6Barr\u00e9 syndrome","volume":"18","author":"Lleix\u00e0","year":"2021","journal-title":"J Neuroinflammation"},{"issue":"3","key":"10.1016\/j.neurol.2023.02.064_bib0725","doi-asserted-by":"crossref","first-page":"449660","DOI":"10.1093\/brain\/122.3.449","article-title":"The distribution of ganglioside-like moieties in peripheral nerves","volume":"122","author":"Sheikh","year":"1999","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.neurol.2023.02.064_bib0730","doi-asserted-by":"crossref","first-page":"3226632","DOI":"10.1167\/iovs.08-3333","article-title":"Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles","volume":"50","author":"Liu","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.neurol.2023.02.064_bib0735","doi-asserted-by":"crossref","first-page":"191167","DOI":"10.1212\/WNL.43.10.1911","article-title":"Serum anti-gq1b igg antibody is associated with ophthalmoplegia in miller fisher syndrome and Guillain-barr\u00e9 syndrome: Clinical and immunohistochemical studies","volume":"43","author":"Chiba","year":"1993","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2023.02.064_bib0740","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/jnnp.70.1.50","article-title":"Anti-GQ1b IgG antibody syndrome: clinical and immunological range","volume":"70","author":"Odaka","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.neurol.2023.02.064_bib0745","doi-asserted-by":"crossref","first-page":"576683","DOI":"10.1136\/jnnp-2012-302824","article-title":"Bickerstaff brainstem encephalitis and Fisher syndrome: Anti-GQ1b antibody syndrome","volume":"84","author":"Shahrizaila","year":"2013","journal-title":"Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.neurol.2023.02.064_bib0750","doi-asserted-by":"crossref","first-page":"158668","DOI":"10.1111\/j.1529-8027.2012.00407.x","article-title":"Clinical and serological features of acute sensory ataxic neuropathy with antiganglioside antibodies","volume":"17","author":"Rojas-Garc\u00eda","year":"2012","journal-title":"J Peripher Nerv Syst"},{"issue":"4","key":"10.1016\/j.neurol.2023.02.064_bib0755","doi-asserted-by":"crossref","first-page":"635644","DOI":"10.1002\/ana.410400414","article-title":"Acute motor axonal neuropathy: An antibody-mediated attack on axolemma","volume":"40","author":"Hafer-Macko","year":"1996","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2023.02.064_bib0760","doi-asserted-by":"crossref","first-page":"1019627","DOI":"10.1007\/s10096-013-2040-4","article-title":"Seroprevalence of campylobacteriosis and relevant post-infectious sequelae","volume":"33","author":"Zautner","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.neurol.2023.02.064_bib0765","doi-asserted-by":"crossref","first-page":"5976605","DOI":"10.1093\/brain\/118.3.597","article-title":"Guillain-barr\u00e9 syndrome in Northern China relationship to Campylobacter jejuni infection and anti-glycolipid antibodies","volume":"118","author":"Ho","year":"1995","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neurol.2023.02.064_bib0770","doi-asserted-by":"crossref","first-page":"836648","DOI":"10.1016\/j.expneurol.2011.12.010","article-title":"Motor nerve terminal destruction and regeneration following anti-ganglioside antibody and complement-mediated injury: An in and ex vivo imaging study in the mouse","volume":"233","author":"Rupp","year":"2012","journal-title":"Exp Neurol"},{"issue":"7","key":"10.1016\/j.neurol.2023.02.064_bib0775","doi-asserted-by":"crossref","first-page":"1944660","DOI":"10.1093\/brain\/awq119","article-title":"Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice","volume":"133","author":"McGonigal","year":"2010","journal-title":"Brain"},{"issue":"17","key":"10.1016\/j.neurol.2023.02.064_bib0780","doi-asserted-by":"crossref","first-page":"6770685","DOI":"10.1523\/JNEUROSCI.4926-14.2015","article-title":"Anti-ganglioside antibodies induce nodal and axonal injury via Fc\u03b3 receptor-mediated inflammation","volume":"35","author":"He","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2023.02.064_bib0785","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3389\/fimmu.2018.01029","article-title":"Autoantibodies against the node of Ranvier in seropositive chronic inflammatory demyelinating polyneuropathy: Diagnostic, pathogenic, and therapeutic relevance","volume":"9","author":"Vural","year":"2018","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.neurol.2023.02.064_bib0790","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1212\/01.WNL.0000160399.08456.7C","article-title":"Antecedent infections in Fisher syndrome","volume":"64","author":"Koga","year":"2005","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.neurol.2023.02.064_bib0795","doi-asserted-by":"crossref","first-page":"94168","DOI":"10.1136\/jnnp-2012-303079","article-title":"Non-demyelinating, reversible conduction failure in Fisher syndrome and related disorders","volume":"83","author":"Umapathi","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"162","key":"10.1016\/j.neurol.2023.02.064_bib0800","first-page":"26630","article-title":"Serial nerve conduction studies provide insight into the pathophysiology of Guillain-Barr\u00e9 and Fisher syndromes","volume":"309","author":"Shahrizaila","year":"2011","journal-title":"J Neurol Sci"},{"issue":"7","key":"10.1016\/j.neurol.2023.02.064_bib0805","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.clinph.2013.01.020","article-title":"Patterns of sensory nerve conduction abnormalities in Fisher syndrome: more predominant involvement of group Ia afferents than skin afferents","volume":"124","author":"Sekiguchi","year":"2013","journal-title":"Clin Neurophysiol"},{"issue":"2","key":"10.1016\/j.neurol.2023.02.064_bib0810","doi-asserted-by":"crossref","first-page":"118624","DOI":"10.1212\/WNL.0000000000000577","article-title":"Antibodies to single glycolipids and glycolipid complexes in Guillain-Barr\u00e9 syndrome subtypes","volume":"83","author":"Shahrizaila","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2023.02.064_bib0815","doi-asserted-by":"crossref","first-page":"62671","DOI":"10.1111\/j.1529-8027.2012.00372.x","article-title":"Nodal proteins are target antigens in Guillain-Barr\u00e9 syndrome","volume":"17","author":"Devaux","year":"2012","journal-title":"J Peripher Nerv Syst"},{"issue":"1","key":"10.1016\/j.neurol.2023.02.064_bib0820","first-page":"28633","article-title":"Epidemiology of chronic inflammatory neuropathies in southeast England","volume":"21","author":"Mahdi-Rogers","year":"2014","journal-title":"Eur J Neurol"},{"issue":"11","key":"10.1016\/j.neurol.2023.02.064_bib0825","first-page":"3214624","article-title":"Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"143","author":"Eftimov","year":"2021","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.neurol.2023.02.064_bib0830","doi-asserted-by":"crossref","first-page":"3556683","DOI":"10.1111\/ene.14959","article-title":"European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force\u2013Second revision","volume":"28","author":"Van den Bergh","year":"2021","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2023.02.064_bib0835","doi-asserted-by":"crossref","first-page":"402612","DOI":"10.1016\/S1474-4422(10)70041-7","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition","volume":"9","author":"Vallat","year":"2010","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.neurol.2023.02.064_bib0840","doi-asserted-by":"crossref","first-page":"637640","DOI":"10.1001\/archneur.1980.00500590061010","article-title":"Immunoglobulin and Complement Deposits in Nerves of Patients with Chronic Relapsing Polyneuropathy","volume":"37","author":"Dalakas","year":"1980","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2023.02.064_bib0845","doi-asserted-by":"crossref","first-page":"231644","DOI":"10.1016\/0165-5728(88)90101-4","article-title":"Immune reactive C3d on the surface of myelin sheaths in neuropathy","volume":"18","author":"Hays","year":"1988","journal-title":"J Neuroimmunol"},{"issue":"6","key":"10.1016\/j.neurol.2023.02.064_bib0850","doi-asserted-by":"crossref","first-page":"765675","DOI":"10.1002\/1531-8249(200006)47:6<765::AID-ANA9>3.0.CO;2-8","article-title":"Passive transfer of demyelination by serum of IgG from chronic inflammatory demyelinating polyneuropathy patients","volume":"47","author":"Yan","year":"2000","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2023.02.064_bib0855","first-page":"1614","article-title":"Chronic inflammatory polyneuropathy. Reduction of nerve conduction velocities in monkeys by systemic passive transfer of immunoglobulin G","volume":"66","author":"Heininger","year":"1984","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.neurol.2023.02.064_bib0860","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41598-017-14853-4","article-title":"Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"7","author":"Querol","year":"2017","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.neurol.2023.02.064_bib0865","doi-asserted-by":"crossref","first-page":"1157663","DOI":"10.1212\/WNL.42.6.1157","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: Comparison of patients with and without an associated monoclonal gammopathy","volume":"42","author":"Bromberg","year":"1992","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurol.2023.02.064_bib0870","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.48.2.321","article-title":"Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy","volume":"48","author":"Gorson","year":"1997","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2023.02.064_bib0875","doi-asserted-by":"crossref","first-page":"8612","DOI":"10.1038\/s41598-019-42545-8","article-title":"Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy","volume":"9","author":"Pascual-Go\u00f1i","year":"2019","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.neurol.2023.02.064_bib0880","doi-asserted-by":"crossref","first-page":"216569","DOI":"10.1007\/s10072-017-3133-0","article-title":"Chronic demyelinating neuropathy with anti-myelin-associated glycoprotein antibody without any detectable M-protein","volume":"38","author":"Sakamoto","year":"2017","journal-title":"Neurol Sci"},{"issue":"5","key":"10.1016\/j.neurol.2023.02.064_bib0885","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.neuron.2019.08.042","article-title":"TREK-1 and TRAAK Are Principal K+ Channels at the Nodes of Ranvier for Rapid Action Potential Conduction on Mammalian Myelinated Afferent Nerves","volume":"104","author":"Kanda","year":"2019","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.neurol.2023.02.064_bib0890","doi-asserted-by":"crossref","first-page":"5616620","DOI":"10.1073\/pnas.090034797","article-title":"Sodium channel Nav1.6 is localized at nodes of Ranvier, dendrites, and synapses","volume":"97","author":"Caldwell","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.neurol.2023.02.064_bib0895","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.1038\/s41583-020-00406-8","article-title":"Mechanisms of node of Ranvier assembly","volume":"22","author":"Rasband","year":"2021","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"10.1016\/j.neurol.2023.02.064_bib0900","doi-asserted-by":"crossref","first-page":"1151661","DOI":"10.1111\/ene.12758","article-title":"The expanding field of IgG4-mediated neurological autoimmune disorders","volume":"22","author":"Huijbers","year":"2015","journal-title":"Eur J Neurol"},{"issue":"51","key":"10.1016\/j.neurol.2023.02.064_bib0905","doi-asserted-by":"crossref","first-page":"2078368","DOI":"10.1073\/pnas.1313944110","article-title":"MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4","volume":"110","author":"Huijbers","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.neurol.2023.02.064_bib0910","doi-asserted-by":"crossref","first-page":"1700612","DOI":"10.1093\/brain\/aww062","article-title":"Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects","volume":"139","author":"Manso","year":"2016","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.neurol.2023.02.064_bib0915","doi-asserted-by":"crossref","first-page":"29063","DOI":"10.1016\/j.nmd.2016.10.008","article-title":"Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies","volume":"27","author":"Vallat","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.1016\/j.neurol.2023.02.064_bib0920","doi-asserted-by":"crossref","first-page":"465673","DOI":"10.1136\/jnnp-2016-314895","article-title":"Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies","volume":"88","author":"Koike","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.neurol.2023.02.064_bib0925","doi-asserted-by":"crossref","first-page":"879686","DOI":"10.1212\/WNL.0000000000000205","article-title":"Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg","volume":"82","author":"Querol","year":"2014","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.neurol.2023.02.064_bib0930","doi-asserted-by":"crossref","first-page":"80067","DOI":"10.1212\/WNL.0000000000002418","article-title":"Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy","volume":"86","author":"Devaux","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurol.2023.02.064_bib0935","doi-asserted-by":"crossref","first-page":"4996501","DOI":"10.1002\/acn3.539","article-title":"Head and voice tremor improving with immunotherapy in an anti-NF155 positive CIDP patient","volume":"5","author":"Painous","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.neurol.2023.02.064_bib0940","doi-asserted-by":"crossref","first-page":"178680","DOI":"10.1016\/j.jneuroim.2019.01.017","article-title":"Tongue tremor in neurofascin-155 IgG4 seropositive chronic inflammatory polyradiculoneuropathy","volume":"330","author":"Briani","year":"2019","journal-title":"J Neuroimmunol"},{"issue":"10","key":"10.1016\/j.neurol.2023.02.064_bib0945","doi-asserted-by":"crossref","first-page":"960671","DOI":"10.1002\/acn3.248","article-title":"Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy","volume":"2","author":"Ogata","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.neurol.2023.02.064_bib0950","first-page":"347651","article-title":"Anti-neurofascin antibody in combined central and peripheral demyelination","volume":"73","author":"Kawamura","year":"2015","journal-title":"Nihon Rinsho"},{"key":"10.1016\/j.neurol.2023.02.064_bib0955","doi-asserted-by":"crossref","first-page":"665136","DOI":"10.3389\/fneur.2021.665136","article-title":"Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy\/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism","volume":"12","author":"Kira","year":"2021","journal-title":"Front Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2023.02.064_bib0960","doi-asserted-by":"crossref","first-page":"848651","DOI":"10.1002\/mus.26010","article-title":"Neurofascin-155 IGG4 Neuropathy: Pathophysiological Insights, Spectrum of Clinical Severity and Response To treatment","volume":"57","author":"Garg","year":"2018","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.neurol.2023.02.064_bib0965","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12974-017-0996-1","article-title":"Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15","volume":"14","author":"Martinez-Martinez","year":"2017","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.neurol.2023.02.064_bib0970","doi-asserted-by":"crossref","first-page":"e1098","DOI":"10.1212\/NXI.0000000000001098","article-title":"Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy","volume":"9","author":"Mart\u00edn-Aguilar","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"10.1016\/j.neurol.2023.02.064_bib0975","doi-asserted-by":"crossref","first-page":"2222636","DOI":"10.1172\/JCI124694","article-title":"Anti6neurofascin-155 IgG4 antibodies prevent paranodal complex formation in vivo","volume":"129","author":"Manso","year":"2019","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.neurol.2023.02.064_bib0980","doi-asserted-by":"crossref","first-page":"e602","DOI":"10.1212\/NXI.0000000000000602","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with contactin-1 antibodies in a child","volume":"6","author":"Carrera-Garc\u00eda","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"10.1016\/j.neurol.2023.02.064_bib0985","doi-asserted-by":"crossref","first-page":"E19621","DOI":"10.1002\/mus.26392","article-title":"Neuro-renal syndrome\u201d related to anti-contactin-1 antibodies","volume":"59","author":"Taieb","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2023.02.064_bib0990","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.3739819","article-title":"Contactin-1 Antibodies Link Autoimmune Neuropathies to Nephrotic Syndrome","author":"Fehmi","year":"2020","journal-title":"SSRN Electronic Journal"},{"key":"10.1016\/j.neurol.2023.02.064_bib0995","doi-asserted-by":"crossref","first-page":"84690","DOI":"10.1016\/j.expneurol.2016.10.006","article-title":"Complement deposition induced by binding of anti-contactin-1 auto-antibodies is modified by immunoglobulins","volume":"287","author":"Appeltshauser","year":"2017","journal-title":"Exp Neurol"},{"issue":"11","key":"10.1016\/j.neurol.2023.02.064_bib1000","doi-asserted-by":"crossref","first-page":"7907618","DOI":"10.1074\/jbc.M113.528489","article-title":"Specific contactin N-glycans are implicated in neurofascin binding and autoimmune targeting in peripheral neuropathies","volume":"289","author":"Labasque","year":"2014","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.neurol.2023.02.064_bib1005","doi-asserted-by":"crossref","first-page":"e01115","DOI":"10.1002\/brb3.1115","article-title":"Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis","volume":"8","author":"Hu","year":"2018","journal-title":"Brain Behav"},{"issue":"10","key":"10.1016\/j.neurol.2023.02.064_bib1010","doi-asserted-by":"crossref","first-page":"1089695","DOI":"10.1136\/jnnp-2021-326343","article-title":"IgG1 pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality","volume":"92","author":"Fehmi","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.neurol.2023.02.064_bib1015","doi-asserted-by":"crossref","first-page":"e603","DOI":"10.1212\/NXI.0000000000000603","article-title":"Anti-pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy","volume":"6","author":"Stengel","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"10.1016\/j.neurol.2023.02.064_bib1020","doi-asserted-by":"crossref","first-page":"627635","DOI":"10.1136\/jnnp-2017-317192","article-title":"Autoimmune nodo-paranodopathies of peripheral nerve: The concept is gaining ground","volume":"89","author":"Uncini","year":"2018","journal-title":"Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.neurol.2023.02.064_bib1025","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/brain\/awy134","article-title":"Subacute nodopathy with conduction blocks and anti-neurofascin 140\/186 antibodies: An ultrastructural study","volume":"141","author":"Vallat","year":"2018","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.neurol.2023.02.064_bib1030","doi-asserted-by":"crossref","first-page":"e817","DOI":"10.1212\/NXI.0000000000000817","article-title":"Antiparanodal antibodies and IgG subclasses in acute autoimmune neuropathy","volume":"7","author":"Appeltshauser","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10.1016\/j.neurol.2023.02.064_bib1035","doi-asserted-by":"crossref","first-page":"e639","DOI":"10.1212\/NXI.0000000000000639","article-title":"Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype","volume":"7","author":"Cortese","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"10.1016\/j.neurol.2023.02.064_bib1040","doi-asserted-by":"crossref","first-page":"1183696","DOI":"10.1093\/brain\/awab014","article-title":"Antibodies to the Caspr1\/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"144","author":"Pascual-Go\u00f1i","year":"2021","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.neurol.2023.02.064_bib1045","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1212\/NXI.0000000000000149","article-title":"Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins","volume":"2","author":"Querol","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"10.1016\/j.neurol.2023.02.064_bib1050","doi-asserted-by":"crossref","first-page":"14068","DOI":"10.1136\/jnnp-2019-321532","article-title":"Multifocal motor neuropathy: controversies and priorities","volume":"91","author":"Yeh","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"13","key":"10.1016\/j.neurol.2023.02.064_bib1055","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1212\/WNL.0b013e31820a96ac","article-title":"Correlates of outcome and response to ivig in 88 patients with multifocal motor neuropathy","volume":"76","author":"Karam","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2023.02.064_bib1060","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.1002\/ana.410240113","article-title":"A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside","volume":"24","author":"Pestronk","year":"1988","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2023.02.064_bib1065","doi-asserted-by":"crossref","first-page":"95165","DOI":"10.1212\/WNL.47.4.951","article-title":"The sensitivity and specificity of anti-GM1 antibody testing","volume":"47","author":"Taylor","year":"1996","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1016\/j.neurol.2023.02.064_bib1070","article-title":"MMN: From immunological cross-talk to conduction block","volume":"34","author":"Harschnitz","year":"2014","journal-title":"J Clin Immunol"},{"issue":"6","key":"10.1016\/j.neurol.2023.02.064_bib1075","doi-asserted-by":"crossref","first-page":"1137641","DOI":"10.1007\/s00415-011-6315-3","article-title":"Associated autoimmune diseases in patients with multifocal motor neuropathy and their family members","volume":"259","author":"Cats","year":"2012","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2023.02.064_bib1080","doi-asserted-by":"crossref","first-page":"305610","DOI":"10.1023\/A:1022497114813","article-title":"Gangliosides and glycosphingolipids of peripheral nervous system myelins - A Minireview","volume":"23","author":"Ogawa-Goto","year":"1998","journal-title":"Neurochem Res"},{"issue":"1","key":"10.1016\/j.neurol.2023.02.064_bib1085","doi-asserted-by":"crossref","first-page":"71688","DOI":"10.1002\/ana.24680","article-title":"Autoantibody pathogenicity in a multifocal motor neuropathy induced pluripotent stem cell6derived model","volume":"80","author":"Harschnitz","year":"2016","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.neurol.2023.02.064_bib1090","doi-asserted-by":"crossref","first-page":"75468","DOI":"10.1136\/jnnp-2013-305755","article-title":"Sensitivity and predictive value of anti-GM1\/galactocerebroside IgM antibodies in multifocal motor neuropathy","volume":"85","author":"Nobile-Orazio","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.neurol.2023.02.064_bib1095","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1468-1331.2001.00187.x","article-title":"Chronic polyneuropathies in Vest-Agder","volume":"8","author":"Mygland","year":"2001","journal-title":"Norway. Eur J Neurol"},{"key":"10.1016\/j.neurol.2023.02.064_bib1100","doi-asserted-by":"crossref","first-page":"450391","DOI":"10.1155\/2015\/450391","article-title":"Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies","volume":"2015","author":"Magy","year":"2015","journal-title":"J Immunol Res"},{"issue":"6","key":"10.1016\/j.neurol.2023.02.064_bib1105","doi-asserted-by":"crossref","first-page":"140269","DOI":"10.1007\/s00415-018-8853-4","article-title":"CANOMAD and other chronic ataxic neuropathies with disialosyl antibodies (CANDA)","volume":"265","author":"Garcia-Santibanez","year":"2018","journal-title":"J Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2023.02.064_bib1110","doi-asserted-by":"crossref","first-page":"629635","DOI":"10.1002\/mus.24192","article-title":"Acute and chronic ataxic neuropathies with disialosyl antibodies: A continuous clinical spectrum and a common pathophysiological mechanism","volume":"49","author":"Yuki","year":"2014","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.neurol.2023.02.064_bib1115","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1111\/ene.15523","article-title":"Anti-disialosyl-immunoglobulin M chronic autoimmune neuropathies: a nationwide multicenter retrospective study","volume":"29","author":"Peillet","year":"2022","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2023.02.064_bib1120","doi-asserted-by":"crossref","first-page":"71683","DOI":"10.1007\/s11940-010-0065-x","article-title":"Pathogenesis and Treatment of Anti-MAG Neuropathy","volume":"12","author":"Dalakas","year":"2010","journal-title":"Curr Treat Options Neurol"},{"issue":"162","key":"10.1016\/j.neurol.2023.02.064_bib1125","first-page":"156663","article-title":"How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?","volume":"266","author":"Nobile-Orazio","year":"2008","journal-title":"J Neurol Sci"},{"issue":"9","key":"10.1016\/j.neurol.2023.02.064_bib1130","doi-asserted-by":"crossref","first-page":"688695","DOI":"10.1212\/WNL.0b013e3181b59a80","article-title":"Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy","volume":"73","author":"Kuijf","year":"2009","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.neurol.2023.02.064_bib1135","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s00415-019-09367-0","article-title":"Relevance of anti-HNK1 antibodies in the management of anti-MAG neuropathies","volume":"266","author":"Delmont","year":"2019","journal-title":"J Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2023.02.064_bib1140","doi-asserted-by":"crossref","first-page":"879682","DOI":"10.1111\/ene.12658","article-title":"Anti-sulfatide IgM antibodies in peripheral neuropathy: To test or not to test?","volume":"22","author":"Giannotta","year":"2015","journal-title":"Eur J Neurol"},{"issue":"8","key":"10.1016\/j.neurol.2023.02.064_bib1145","doi-asserted-by":"crossref","first-page":"103067","DOI":"10.1002\/(SICI)1097-4598(199908)22:8<1030::AID-MUS4>3.0.CO;2-H","article-title":"Anti-MAG IgM penetration into myelinated fibers correlates with the extent of myelin widening","volume":"22","author":"Ritz","year":"1999","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.neurol.2023.02.064_bib1150","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1212\/WNL.37.2.242","article-title":"Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein","volume":"37","author":"Hays","year":"1987","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurol.2023.02.064_bib1155","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ana.410330514","article-title":"Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein","volume":"33","author":"Tatum","year":"1993","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2023.02.064_bib1160","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/brain\/awx012","article-title":"Co-cultures with stem cell-derived human sensory neurons reveal regulators of peripheral myelination","volume":"140","author":"Clark","year":"2017","journal-title":"Brain"},{"issue":"24","key":"10.1016\/j.neurol.2023.02.064_bib1165","doi-asserted-by":"crossref","first-page":"2217625","DOI":"10.1212\/WNL.0b013e318296e92b","article-title":"Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy","volume":"80","author":"L\u00e9ger","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurol.2023.02.064_bib1170","doi-asserted-by":"crossref","first-page":"286693","DOI":"10.1002\/ana.21577","article-title":"Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy","volume":"65","author":"Dalakas","year":"2009","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2023.02.064_bib1175","doi-asserted-by":"crossref","first-page":"984696","DOI":"10.3324\/haematol.2013.100552","article-title":"The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: Recommendations from the European Myeloma Network","volume":"99","author":"Van de Donk","year":"2014","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.neurol.2023.02.064_bib1180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1468-1331.1999.610071.x","article-title":"Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies","volume":"6","author":"Willison","year":"1999","journal-title":"Eur J Neurol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378723008718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378723008718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:47:15Z","timestamp":1758520035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378723008718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":118,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0035378723008718"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2023.02.064","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2023.02.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}